JP2018508523A5 - - Google Patents

Download PDF

Info

Publication number
JP2018508523A5
JP2018508523A5 JP2017546149A JP2017546149A JP2018508523A5 JP 2018508523 A5 JP2018508523 A5 JP 2018508523A5 JP 2017546149 A JP2017546149 A JP 2017546149A JP 2017546149 A JP2017546149 A JP 2017546149A JP 2018508523 A5 JP2018508523 A5 JP 2018508523A5
Authority
JP
Japan
Prior art keywords
composition
cochleates
cocreatate
tissue
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017546149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018508523A (ja
JP6770524B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/020722 external-priority patent/WO2016141203A1/en
Publication of JP2018508523A publication Critical patent/JP2018508523A/ja
Publication of JP2018508523A5 publication Critical patent/JP2018508523A5/ja
Application granted granted Critical
Publication of JP6770524B2 publication Critical patent/JP6770524B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017546149A 2015-03-03 2016-03-03 コクリエート、及び薬理活性物質の組織透過性を高めるためにそれを使用する方法 Active JP6770524B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201562127799P 2015-03-03 2015-03-03
US62/127,799 2015-03-03
US201562162425P 2015-05-15 2015-05-15
US62/162,425 2015-05-15
US201562163212P 2015-05-18 2015-05-18
US62/163,212 2015-05-18
US201562239675P 2015-10-09 2015-10-09
US62/239,675 2015-10-09
US201562247641P 2015-10-28 2015-10-28
US62/247,641 2015-10-28
US201562264164P 2015-12-07 2015-12-07
US62/264,164 2015-12-07
PCT/US2016/020722 WO2016141203A1 (en) 2015-03-03 2016-03-03 Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent

Publications (3)

Publication Number Publication Date
JP2018508523A JP2018508523A (ja) 2018-03-29
JP2018508523A5 true JP2018508523A5 (enExample) 2019-03-28
JP6770524B2 JP6770524B2 (ja) 2020-10-14

Family

ID=56848705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017546149A Active JP6770524B2 (ja) 2015-03-03 2016-03-03 コクリエート、及び薬理活性物質の組織透過性を高めるためにそれを使用する方法

Country Status (8)

Country Link
US (1) US11389407B2 (enExample)
EP (1) EP3265060B1 (enExample)
JP (1) JP6770524B2 (enExample)
KR (1) KR20180004104A (enExample)
CN (1) CN107847443A (enExample)
AU (1) AU2016226151B2 (enExample)
CA (1) CA2978308C (enExample)
WO (1) WO2016141203A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7285261B2 (ja) * 2017-09-20 2023-06-01 アトピック・メディカル・インコーポレイテッド 呼吸器状態及び粘膜の炎症を治療及び改善するための組成物及び方法
CN107621514B (zh) * 2017-11-10 2020-09-29 成都美域高制药有限公司 高效液相色谱法测定磷酸特地唑胺对映异构体含量的方法
KR101989789B1 (ko) * 2017-11-30 2019-06-18 (주) 에이치엔에이파마켐 포스파티딜세린/음이온계면활성제/염화칼슘을 이용한 코킬레이트
WO2019199238A1 (en) * 2018-04-09 2019-10-17 Vet Products Research And Innovation Center Company Limited Inorganic mineral entrapped in nanoparticle production method thereof
CA3146601A1 (en) * 2019-08-13 2021-02-18 Matinas Biopharma Nanotechnologies, Inc. Methods of treating cryptococcus infections
WO2024039733A1 (en) 2022-08-16 2024-02-22 Matinas Biopharma Nanotechnologies, Inc. Methods of controlling lipid nanocrystal particle size and lipid nanocrystals produced by such methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871488A (en) 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
US5643574A (en) 1993-10-04 1997-07-01 Albany Medical College Protein- or peptide-cochleate vaccines and methods of immunizing using the same
US5994318A (en) 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
US6153217A (en) 1999-01-22 2000-11-28 Biodelivery Sciences, Inc. Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
US20030219473A1 (en) * 2002-03-26 2003-11-27 Leila Zarif Cochleates made with purified soy phosphatidylserine
CN1674869A (zh) 2002-08-06 2005-09-28 金拓 非金属阳离子作桥联剂的脂质卷
US20050008686A1 (en) * 2003-01-15 2005-01-13 Mannino Raphael J. Cochleate preparations of fragile nutrients
EP1624858B1 (en) * 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Novel encochleation methods
JP4789208B2 (ja) 2003-04-09 2011-10-12 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド タンパク質発現に向けられた渦巻型組成物
SG190613A1 (en) * 2003-07-16 2013-06-28 Protiva Biotherapeutics Inc Lipid encapsulated interfering rna
EP1737427A2 (en) * 2004-04-09 2007-01-03 Biodelivery Sciences International, Inc. Nucleotide-cochleate compositions and methods of use
CA2834788C (en) 2011-05-05 2020-11-17 Coordinated Program Development, Llc Cochleate compositions and methods of making and using same
WO2013085152A1 (en) * 2011-12-07 2013-06-13 Union Korea Pharm Co., Ltd. Combined antibiotics comprising cephalosporins and beta-lactamase inhibitors
US20150297725A1 (en) * 2012-07-30 2015-10-22 Rutgers, The State University Of New Jersey Cochleates made with soy phosphatidylserine
KR20180004168A (ko) 2015-04-22 2018-01-10 마티나스 바이오파마 나노테크놀로지스, 인코포레이티드 마이코박테리아 감염 및 폐 질환 치료를 위한 조성물 및 방법
WO2016205654A1 (en) 2015-06-18 2016-12-22 Aquarius Biotechnologies, Inc. Compositions and methods for treating inflammatory disease or conditions

Similar Documents

Publication Publication Date Title
US11518796B2 (en) Engineered platelets for targeted delivery of a therapeutic agent
Peng et al. Local release of TGF‐β inhibitor modulates tumor‐associated neutrophils and enhances pancreatic cancer response to combined irreversible electroporation and immunotherapy
US20250195641A1 (en) Immunotherapeutic constructs and methods of their use
US20170042924A1 (en) Muscle atrophy inhibitor containing quercetin glycoside
JP2016515533A5 (enExample)
CA3139714A1 (en) Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
BR112015009504A2 (pt) inibidores de rock
WO2021011496A1 (en) Immunotherapeutic constructs and methods of their use
Fang et al. Atorvastatin suppresses Toll-like receptor 4 expression and NF-κB activation in rabbit atherosclerotic plaques.
Hu et al. Brucine inhibits bone metastasis of breast cancer cells by suppressing Jagged1/Notch1 signaling pathways
ES2879881T3 (es) Composiciones que comprenden partículas de nanosílice y su uso en métodos de activación de linfocitos T para terapia
Zheng et al. A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation
Chen et al. Leukocyte–mimicking Pluronic–lipid nanovesicle hybrids inhibit the growth and metastasis of breast cancer
JP2018537514A5 (enExample)
Yin et al. An immune‐enhancing injectable hydrogel loaded with esketamine and DDP promotes painless immunochemotherapy to inhibit breast cancer growth
SI3099307T1 (en) Use of cladribine for the treatment of neuromyelitis of the visual nerve
JP2018528319A (ja) 抗転移性海洋細菌性菌体外多糖誘導体及びその使用
CN114040751A (zh) 针对微卫星稳定型结直肠癌通过协同性免疫原性细胞死亡促进抗肿瘤响应的槲皮素和土木香内酯的纳米共递送
US20180360964A1 (en) Pharmaceutical composition and a method for producing thereof
Fragassi Rational development of intra-articular drug delivery systems for the treatment of osteoarthritis
EP4588511A3 (en) Intestinal alkaline phosphatase-based treatments of metabolic disorders
KR101577271B1 (ko) 칼슘 이온 및 친수성 비스포스포네이트를 이용한 나노복합체의 제조방법 및 상기 나노복합체를 이용한 약물전달체
CN114072167B (zh) 寄生虫和从寄生虫获得的细胞外囊泡在癌症治疗中的用途
Gile et al. Potential mechanisms of intestinal microbes in bone metastasis of breast cancer
Niknafs et al. An Approach to New Treatments for Osteoarthritis: Advancing Phenotype-Specific Treatments and the Promise of Nanotechnology in Drug Delivery